GLPG0187 is a broad spectrum integrin receptor antagonist with antitumor activity; inhibits α v β 1 -integrin with an IC 50 of 1.3 nM. GLPG0187 inhibits migrasome biogenesis without cytotoxicity.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Cytoskeleton | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Integrin
感谢您来到爆牛贸易,请为我们留言或者使用以下方式联系我们,我们将尽快给您回复,并为您提供最真诚的服务,谢谢。